The International Bladder Cancer Group provides global consensus recommendations from a multidisciplinary team regarding optimal sequencing of therapy in muscle-invasive bladder cancer. The recommendations emphasize multidisciplinary care, perioperative treatment selection, and endpoints for clinical trials in this rapidly evolving space.
European Urology published a clinical update in Research Highlights on 21 Feb 2026.
The item focuses on Optimal Management of Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.
Review the original article for the full source wording and details.